Home / Technology Incubation Program / List of Clients
Current Companies
Agrivida
Agrivida is an agricultural biotechnology company focused on creating renewable, biomass-based alternative fuels and raw materials. Agrivida is developing corn varieties that are optimized for producing ethanol from corn stover, otherwise known as “cellulosic” ethanol.
Amastan
Amastan will manufacture and market products based upon patented technologies developed by Amastan founder. These products will initially be directed to meet a need in the energy and environmental sectors for cost-competitive and high-quality diagnostics and energy-enabling systems.
AquaSeNT
Aquatic Sensor Network Technology (AquaSeNT) is a small business with a focus on developing innovative and comprehensive underwater wireless communication and networking solutions.
Arbor Fuel
Arbor Fuel LLC is a technology company formed to utilize the power of biotechnology for the generation of alternative fuels. Advancements in the understanding of microbiological processing of cellulose based plant material have opened the opportunity to generate cell lines and biological processes to covert cellulosic material into fuel. The company believes that by coupling genomic approaches with the advanced cell culturing technologies utilized in biotherapeutic drug development they can make cell lines for cost effective generation of fuel from plant material a reality.
Arcanatura
Arcanatura’s aim is the development, manufacturing and global commercialization of natural Animal Health products (mainly from plant origin) with demonstrated superior customer value, as alternatives and/or complements to traditional pharmaceutical products derived from chemistry.
Cryotooth
Cryotooth was founded in 2003 on the vision of enabling people with the ability to receive advance cellular treatments with their own personal cells. Cryotooth collects and stores stem cells found in teeth, as well as conducting advanced dental stem cell research.
Doctors Research Group
The Doctors Research Group (DRG) focuses on producing and marketing medical products. Currently, they are focusing on the development of a new type of bone cement or bone glue called Kryptonite.
eGen
eGen is developing a novel modular low cost system that produces clean sustainable electrical energy utilizing relatively slow water flow across an airfoil.
Escientia
Escientia is a contract research organization that collaborates with R&D departments of biotechnology and biopharmaceutical companies to discover and develop new medicines. The company also engages in its own new drug discovery agenda to develop treatments of treat tropical diseases such as malaria.
Global Blood Resources
Global Blood Resources is a company that is making advances in whole blood recovery, salvaging, and transfusions. Their main product is the Hemobag which is a device that returns a patient’s own blood to their body during invasive surgery. This product is an affordable alternative to risky transfusions.
IMCORP
IMCORP is the leading provider of underground power cable reliability enhancement solutions. The company’s patented partial discharge (PD) diagnostic technology pinpoints the exact location of cable defects with unsurpassed accuracy. In addition to locating existing cable and accessory defects, IMCORP’s non-destructive test methodology provides predictive diagnostic information concerning future cable performances.
MAKScientific
MAKScientific is a leader in endocannabinoid research with the ability to address major unmet medical needs for selected diseases with clear competitive advantage over present therapies. The company’s mission is the discovery, development and commercialization of novel therapeutics in the areas of neuropathic, inflammatory and somatic pain, obesity, neuroprotection, and addiction and glaucoma.
MysticMD™ Inc.
MysticMD™ Inc. is leveraging specific attributes of carbon nanotube based conductive coatings for applications in power, security, medical, and performance coatings markets.
OPEL
OPEL – a later stage company, based on technology developed by of Geoff Taylor, that designs and manufactures Solar Concentrating products for use in the generation of power for commercial applications.
OSCI/Biorasis
OSCI/Biorasis was formed by Faquir Jain and Fotios Papadimitrakopoulos to commercialize a minimally invasive glucose sensor. BIORASIS Inc., is a start-up corporation to commercialize implantable biosensors using University of Connecticut (UCONN) spin-off technology. Currently, we are at the last stages of developing a wireless, needle-implantable, miniaturized (0.5 ?x 0.5 x 5 mm) glucose sensor for real-time, continuous glucose monitoring.
Revegen
Revegen is a research-based pharmaceutical company that identifies new therapeutically active molecules through novel, proprietary technology – PDICAD – improving the efficiency of the drug discovery process.
RibogeniX
RibogeniX is a RNA genomics company dedicated to the study of human sequence variants that regulate gene expression at the RNA level. Its mission is to apply this knowledge to the diagnosis and treatment of human disease. Our platform technology is the ability to discern and functionally test aberrant RNA: RNA interactions caused by sequence variants. We will focus on genes that are of immediate relevance to human disease. Soon, we will launch a service that will provide information on disease risks associated with common human sequence variants in the BRCA1 gene.
Synaptic Dynamics
Synaptic Dynamics, incorporated in October 2006, is involved in research on lysosomal activity as a basis for developing drugs for the treatment of neurodegenerative diseases, particularly Alzheimer’s Disease.
Systamedic
Systamedic is an emerging pharmacology-based research company that was formed by a group of medicinal chemists. The company utilizes a sophisticated bio-computing technology to identify cellular circuits involved in the generation of drug effects as a novel platform for drug discovery.
Graduated Companies
AllerQuest
AllerQuest was established by a team including Emeritus Professor Charlotte Ressler, specifically to further develop and produce skin test reagents to safely and accurately identify patients who are at risk for potentially life threatening reactions to penicillin antibiotics. The firm has developed a GMP facility in Plainville to support production and sales of their first product Pre-Pen.
Catelectric Corporation
Catelectric Corporation is collaborating with Professor Steven Suib in chemistry and is developing catalytic systems for qualitative advances in pollution control and hydrogen generation. Catelectric Corporation has developed and laboratory proven a system of electronic control for catalytic reactions, named “DECAN”. The system operates effectively on gaseous or liquid reactants and electrical energy required to operate the system is very low.
Conversion Energy Enterprises
Conversion Energy Enterprises specializes in design and development of medical systems utilizing advanced concepts in electronic lasers and biomaterials with a focus on laser assisted joining of tissue. CEE spin out, LumeNora, is pursing FDA approval and commercialization for an ophthalmic application of CEE technology.
Evergen Biotechnology
Evergen Biotechnology, founded by UCONN Professor Jerry Yang, to improve dairy productivity and commercialize transgenic technology, graduated in July 08 and is now located in Vernon, CT. They will continue to collaborate with the CRB to further their transgenic animal work.
Lifepharms, Inc.
Lifepharms, Inc. is researching natural products for medicinal and agricultural uses, including anticancer and pox virus medications.
Synaptic Dynamics, incorporated in October 2006, is involved in a research on lysosomal activity as a basis for developing drugs for treatment of neurodegenerative diseases, particularly Alzheimer’s Disease.
